Axiom University
Fusion eClinical Suite – Training Material

Fusion eClinical Suite

Data Driven Studies: Fusion is Axiom’s proprietary, easy-to-use and cost-effective eClinical solution that is focused on small to medium sized device, pharma, and biotech companies.

Over 15 fully integrated modules that connect seamlessly in one unified platform – accessible with a single sign-on.

Training Material

Axiom offers the following training material(s) available for the MIRUM PHARMA – MRX-310 study:

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.

MRX-310 Study

The goal of this observational study is to evaluate the long-term safety and clinical outcomes of LIVMARLI prescribed to patients in the United States (LEAP-US).